MX2019013120A - Composicion que contiene dioxido de cloro y metodos para su uso. - Google Patents
Composicion que contiene dioxido de cloro y metodos para su uso.Info
- Publication number
- MX2019013120A MX2019013120A MX2019013120A MX2019013120A MX2019013120A MX 2019013120 A MX2019013120 A MX 2019013120A MX 2019013120 A MX2019013120 A MX 2019013120A MX 2019013120 A MX2019013120 A MX 2019013120A MX 2019013120 A MX2019013120 A MX 2019013120A
- Authority
- MX
- Mexico
- Prior art keywords
- chlorine dioxide
- methods
- same
- composition containing
- containing chlorine
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/20—Elemental chlorine; Inorganic compounds releasing chlorine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0048—Eye, e.g. artificial tears
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/02—Local antiseptics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P41/00—Drugs used in surgical methods, e.g. surgery adjuvants for preventing adhesion or for vitreum substitution
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/127—Liposomes
- A61K9/1271—Non-conventional liposomes, e.g. PEGylated liposomes, liposomes coated with polymers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/51—Nanocapsules; Nanoparticles
- A61K9/5107—Excipients; Inactive ingredients
- A61K9/513—Organic macromolecular compounds; Dendrimers
- A61K9/5146—Organic macromolecular compounds; Dendrimers obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, polyamines, polyanhydrides
- A61K9/5153—Polyesters, e.g. poly(lactide-co-glycolide)
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Epidemiology (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Ophthalmology & Optometry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Inorganic Chemistry (AREA)
- Surgery (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Dermatology (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Dispersion Chemistry (AREA)
Abstract
La presente invención se refiere a una composición que comprende dióxido de cloro útil para el tratamiento de infecciones activas del ojo, así como a la profilaxis y el tratamiento de tales infecciones. La invención también se refiere a los usos de composiciones que incluyen cantidades efectivas de dióxido de cloro en el ojo para obtener un beneficio sin afectar negativamente al ojo.
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201762502085P | 2017-05-05 | 2017-05-05 | |
US201762608889P | 2017-12-21 | 2017-12-21 | |
PCT/US2018/031318 WO2018204905A1 (en) | 2017-05-05 | 2018-05-07 | Composition containing chlorine dioxide and methods for using same |
Publications (1)
Publication Number | Publication Date |
---|---|
MX2019013120A true MX2019013120A (es) | 2020-07-28 |
Family
ID=64014393
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MX2023002113A MX2023002113A (es) | 2017-05-05 | 2018-05-07 | Composicion que contiene dioxido de cloro y metodos para su uso. |
MX2019013120A MX2019013120A (es) | 2017-05-05 | 2018-05-07 | Composicion que contiene dioxido de cloro y metodos para su uso. |
Family Applications Before (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MX2023002113A MX2023002113A (es) | 2017-05-05 | 2018-05-07 | Composicion que contiene dioxido de cloro y metodos para su uso. |
Country Status (5)
Country | Link |
---|---|
US (2) | US10925894B2 (es) |
EP (1) | EP3618613A4 (es) |
CA (1) | CA3062420A1 (es) |
MX (2) | MX2023002113A (es) |
WO (1) | WO2018204905A1 (es) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US11944097B2 (en) | 2019-07-01 | 2024-04-02 | Aseptic Health, LLC | Antimicrobial composition |
US20210145861A1 (en) * | 2019-11-18 | 2021-05-20 | Gregory J. PAMEL | Chitosan containing compositions and methods relating to same |
CN112841215B (zh) * | 2020-12-30 | 2022-02-25 | 唐山市紫淳科技有限公司 | 一种固载二氧化氯空气消毒颗粒及其制备方法和应用 |
EP4056038A1 (en) * | 2021-03-10 | 2022-09-14 | Basf Se | Microparticles containing active substances |
Family Cites Families (19)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3278447A (en) | 1963-12-02 | 1966-10-11 | Cloro Bac Products Inc | Process for stabilizing chlorine dioxide solution |
US4177268A (en) | 1973-05-30 | 1979-12-04 | Jouveinal S.A. | Method of alleviating inflammation by administration of dexamethasone derivatives |
US5736165A (en) * | 1993-05-25 | 1998-04-07 | Allergan | In-the-eye use of chlorine dioxide-containing compositions |
AU2825795A (en) * | 1994-06-23 | 1996-01-19 | Allergan, Inc. | Contact lens cleaning compositions with solubilized polymers |
PE20020146A1 (es) * | 2000-07-13 | 2002-03-31 | Upjohn Co | Formulacion oftalmica que comprende un inhibidor de ciclooxigenasa-2 (cox-2) |
AR031135A1 (es) * | 2000-10-10 | 2003-09-10 | Upjohn Co | Composiciones de antibiotico topico para el tratamiento de infecciones oculares |
US20050042240A1 (en) * | 2002-01-28 | 2005-02-24 | Utterberg David S. | High viscosity antibacterials |
US8273366B2 (en) * | 2002-06-05 | 2012-09-25 | University Of Florida Research Foundation, Incorporated | Ophthalmic drug delivery system |
US20040224010A1 (en) * | 2002-11-15 | 2004-11-11 | Optime Therapeutics, Inc. | Ophthalmic liposome compositions and uses thereof |
US7083802B2 (en) * | 2003-07-31 | 2006-08-01 | Advanced Ocular Systems Limited | Treatment of ocular disease |
US7157412B2 (en) * | 2004-04-07 | 2007-01-02 | Advanced Medical Optics, Inc. | Alkylamine as an antimicrobial agent in ophthalmic compositions |
US7767217B2 (en) | 2006-03-14 | 2010-08-03 | Foresight Biotherapeutics | Ophthalmic compositions comprising povidone-iodine |
CN1820607A (zh) | 2006-03-31 | 2006-08-23 | 东华大学 | 一种二氧化氯缓释微胶囊的制备方法 |
US20080020064A1 (en) * | 2006-07-21 | 2008-01-24 | Advanced Vision Research | Methods and compositions for the treatment of infection or infectious colonization of the eyelid, ocular surface, skin or ear |
US8311625B2 (en) * | 2009-02-04 | 2012-11-13 | Basf Corporation | Chlorine dioxide treatment for biological tissue |
US20130251783A1 (en) * | 2011-09-14 | 2013-09-26 | Universitat Heidelberg | Liposomes containing permeation enhancers for oral drug delivery |
CN102429862B (zh) | 2011-11-29 | 2013-05-01 | 江苏德达医药科技有限公司 | 一种聚维酮碘眼用缓释滴眼液 |
EP2844295A1 (en) * | 2012-05-03 | 2015-03-11 | Kala Pharmaceuticals, Inc. | Pharmaceutical nanoparticles showing improved mucosal transport |
KR20170012094A (ko) * | 2015-07-21 | 2017-02-02 | 주식회사 바이오건강생활 | 이산화염소 제어 방출용 나노입자 제조방법 및 그 용도 |
-
2018
- 2018-05-07 US US15/972,362 patent/US10925894B2/en active Active
- 2018-05-07 WO PCT/US2018/031318 patent/WO2018204905A1/en unknown
- 2018-05-07 MX MX2023002113A patent/MX2023002113A/es unknown
- 2018-05-07 EP EP18794687.6A patent/EP3618613A4/en active Pending
- 2018-05-07 MX MX2019013120A patent/MX2019013120A/es unknown
- 2018-05-07 CA CA3062420A patent/CA3062420A1/en active Pending
-
2021
- 2021-02-22 US US17/180,995 patent/US20210177890A1/en active Pending
Also Published As
Publication number | Publication date |
---|---|
WO2018204905A1 (en) | 2018-11-08 |
US10925894B2 (en) | 2021-02-23 |
EP3618613A1 (en) | 2020-03-11 |
MX2023002113A (es) | 2023-03-15 |
CA3062420A1 (en) | 2018-11-08 |
EP3618613A4 (en) | 2021-01-20 |
US20210177890A1 (en) | 2021-06-17 |
US20180318339A1 (en) | 2018-11-08 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
PH12019500932A1 (en) | 2,4,5-trisubstituted 1,2,4-triazolones useful as inhibitors of dhodh | |
MX2018000351A (es) | Composición para el cuidado de telas que comprende poliolésteres insaturados metatesizados. | |
MX2019001096A (es) | Antagonistas del receptor 7/8 tipo toll (tlr7/8) y uso de los mismos. | |
MX2019013120A (es) | Composicion que contiene dioxido de cloro y metodos para su uso. | |
AU2016278853A8 (en) | Petrolatum-based compositions comprising cationic biocides | |
SG10201908839QA (en) | 2,4-dihydroxy-nicotinamides as apj agonists | |
CR20210108A (es) | Benzamidas sustituidas con 1, 3-tiazol-2-ilo | |
MX2017011711A (es) | Mejora en o con relacion a compuestos organicos. | |
EP4248968A3 (en) | Tlr7/8 antagonists and uses thereof | |
MX2017012545A (es) | Compuestos heterociclicos y su uso en la prevencion o tratamiento de las infecciones bacterianas. | |
PH12020500134A1 (en) | Dihydrooxadiazinones | |
PH12017501133A1 (en) | Pyrazolopyridinamines | |
PH12018501575A1 (en) | Indolinones compounds and their use in the treatment of fibrotic diseases | |
MX2020001885A (es) | Formulaciones de daptomicina. | |
MX2020006596A (es) | Hidroxiisoxazolinas y derivados de estos. | |
MX2017016231A (es) | Compuestos de aminobencisoxazol como agonistas de receptores a7-nicotínicos de acetilcolina. | |
EA201992509A1 (ru) | Гетероарилфениламинохинолины и аналоги | |
MX2017012535A (es) | Compuestos hetorociclicos novedosos y su uso en la prevencion o tratamiento de las infecciones bacterianas. | |
NZ764310A (en) | Antibacterial compounds | |
MX2021015544A (es) | Formulaciones de oxido de polialquileno-asparaginasa y metodos de preparacion y uso del mismo. | |
MX2017014080A (es) | Compuestos heterociclicos y su uso en la prevencion o tratamiento de las infecciones bacterianas. | |
MX2019011908A (es) | Macrociclos de peptidos anti-bacterianos y uso de los mismos. | |
PH12018500358A1 (en) | Compounds for use in an antibacterial applications | |
PH12019502083A1 (en) | Preparation containing at least fludioxonil and a mixture containing aureobasidium pullulans strains | |
MX2018011095A (es) | Compuestos de carbapenem. |